These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37800816)
1. Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT. Zhang N; Zhang S; Ma L; Qiu L; Meng QL; Cai J; Xu Z; Yao H; Fan FY Medicine (Baltimore); 2023 Oct; 102(40):e35413. PubMed ID: 37800816 [TBL] [Abstract][Full Text] [Related]
2. Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review. Li L; Wu C; Chai Y; Dong C; Zhao L Int J Immunopathol Pharmacol; 2021; 35():20587384211009342. PubMed ID: 33845613 [TBL] [Abstract][Full Text] [Related]
3. Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine. Yuan L; Sun L; Bo J; Zhou Y; Li HH; Yu L; Gao CJ Ann Transplant; 2011; 16(3):135-8. PubMed ID: 21959522 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma. Gibson JF; Alpdogan O; Subtil A; Girardi M; Wilson LD; Roberts K; Foss F J Am Acad Dermatol; 2015 Jun; 72(6):1010-5.e5. PubMed ID: 25981001 [TBL] [Abstract][Full Text] [Related]
5. Familial aggregation of subcutaneous panniculitis-like T cell lymphoma: A case report of monozygotic twin brothers. Shen XZ; Yu SL; Liu F; Luo ZY Medicine (Baltimore); 2020 Oct; 99(42):e22629. PubMed ID: 33080699 [TBL] [Abstract][Full Text] [Related]
6. Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma. Zong X; Yang Z; Zhou J; Jin Z; Wu D Front Immunol; 2024; 15():1430648. PubMed ID: 39229263 [TBL] [Abstract][Full Text] [Related]
7. Relapsed subcutaneous panniculitis-like T cell lymphoma evaluated by FDG PET/CT: A clinical case report. Dong P; Wang L; Zhu H; Li L Medicine (Baltimore); 2018 Nov; 97(46):e12980. PubMed ID: 30431571 [TBL] [Abstract][Full Text] [Related]
8. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report. Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836 [TBL] [Abstract][Full Text] [Related]
9. The pathophysiology and current treatments for the subcutaneous panniculitis-like T cell lymphoma: An updated review. Lin EC; Liao JB; Fang YH; Hong CH Asia Pac J Clin Oncol; 2023 Feb; 19(1):27-34. PubMed ID: 35509196 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation. Jung HR; Yun SY; Choi JH; Bae SH; Ryoo HM; Kum YS Cancer Res Treat; 2011 Dec; 43(4):255-9. PubMed ID: 22247712 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis: a systematic review of 63 patients reported in the literature. Ou W; Zhao Y; Wei A; Ma H; Zhang L; Lian H; Zhang Q; Wang D; Li Z; Wang T; Zhang R Clin Exp Med; 2023 Dec; 23(8):4575-4583. PubMed ID: 37840116 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. Wang W; Zhang W; Su LP; Liu LH; Gao YH; Wang QS; Su H; Song YQ; Zhang HL; Shen J; Jing HM; Wang SY; Cen XN; Liu H; Liu AC; Li ZJ; Luo JM; He JX; Wang JW; O'Connor OA; Zhou DB Ann Hematol; 2024 Aug; 103(8):3061-3069. PubMed ID: 38805037 [TBL] [Abstract][Full Text] [Related]
14. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Shi Y; Dong M; Hong X; Zhang W; Feng J; Zhu J; Yu L; Ke X; Huang H; Shen Z; Fan Y; Li W; Zhao X; Qi J; Huang H; Zhou D; Ning Z; Lu X Ann Oncol; 2015 Aug; 26(8):1766-71. PubMed ID: 26105599 [TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 19 cases of subcutaneous panniculitis T-cell lymphoma with literature review]. Huang JJ; Cai MY; Ye S; Li ZM; Huang HQ; Lin TY Ai Zheng; 2009 Oct; 28(10):1093-9. PubMed ID: 19799820 [TBL] [Abstract][Full Text] [Related]
16. Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma. Wang J; Fang Y; Ma S; Su N; Zhang Y; Huang H; Li Z; Huang H; Tian X; Cai J; Xia Y; Liu P; Cai Q Leuk Res; 2021 Dec; 111():106705. PubMed ID: 34534908 [TBL] [Abstract][Full Text] [Related]
19. Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation. Reimer P; Rüdiger T; Müller J; Rose C; Wilhelm M; Weissinger F Ann Hematol; 2003 May; 82(5):305-9. PubMed ID: 12707721 [TBL] [Abstract][Full Text] [Related]
20. Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment. Merdin A; İskender D; Ulu BU; Doğan M; Çakar MK; Dal MS; Altuntaş F Medicine (Baltimore); 2019 Jul; 98(30):e16482. PubMed ID: 31348254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]